Education
About Us
Working with TipRanks
Follow Us
Santen Pharmaceutical Co Ltd (SNPHY)
OTHER OTC:SNPHY
| Mar 25 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 301.96B | ¥ 300.00B | ¥ 279.04B | ¥ 266.26B | ¥ 249.60B |
| Gross Profit | ¥ 178.71B | ¥ 171.03B | ¥ 166.09B | ¥ 156.59B | ¥ 151.38B |
| Operating Income | ¥ 38.54B | ¥ 46.88B | ¥ -3.09B | ¥ 35.89B | ¥ 37.80B |
| EBITDA | ¥ 50.72B | ¥ 59.01B | ¥ 12.95B | ¥ 52.93B | ¥ 70.28B |
| Net Income | ¥ 26.64B | ¥ 36.26B | ¥ -14.95B | ¥ 27.22B | ¥ 6.83B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 94.96B | ¥ 93.99B | ¥ 58.68B | ¥ 84.31B | ¥ 63.41B |
| Total Assets | ¥ 435.70B | ¥ 409.28B | ¥ 421.18B | ¥ 459.98B | ¥ 402.35B |
| Total Debt | ¥ 35.16B | ¥ 34.23B | ¥ 36.21B | ¥ 32.93B | ¥ 10.15B |
| Net Debt | ¥ -59.42B | ¥ -93.00B | ¥ -21.70B | ¥ -50.08B | ¥ -52.74B |
| Total Liabilities | ¥ 130.33B | ¥ 124.10B | ¥ 127.88B | ¥ 123.13B | ¥ 95.30B |
| Stockholders' Equity | ¥ 306.06B | ¥ 286.24B | ¥ 293.98B | ¥ 337.49B | ¥ 307.58B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 61.96B | ¥ 54.27B | ¥ 12.56B | ¥ 10.20B | ¥ 15.00B |
| Operating Cash Flow | ¥ 72.65B | ¥ 60.93B | ¥ 37.15B | ¥ 46.04B | ¥ 38.81B |
| Investing Cash Flow | ¥ -6.14B | ¥ -8.22B | ¥ -26.78B | ¥ -35.17B | ¥ -53.35B |
| Financing Cash Flow | ¥ -34.03B | ¥ -53.31B | ¥ -37.22B | ¥ 5.56B | ¥ -16.68B |